tradingkey.logo

HCA Healthcare Inc

HCA
472.070USD
-6.950-1.45%
Fechamento 01/09, 16:00ETCotações atrasadas em 15 min
108.50BValor de mercado
18.04P/L TTM

HCA Healthcare Inc

472.070
-6.950-1.45%

Mais detalhes de HCA Healthcare Inc Empresa

HCA Healthcare, Inc. is a health care services company. It owns, manages or operates hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals and 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

Informações de HCA Healthcare Inc

Código da empresaHCA
Nome da EmpresaHCA Healthcare Inc
Data de listagemDec 28, 2010
CEOHazen (Samuel N)
Número de funcionários226000
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 28
EndereçoOne Park Plaza
CidadeNASHVILLE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal37203
Telefone16153449551
Sitehttps://hcahealthcare.com/
Código da empresaHCA
Data de listagemDec 28, 2010
CEOHazen (Samuel N)

Executivos da empresa HCA Healthcare Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Samuel N. (Sam) Hazen
Mr. Samuel N. (Sam) Hazen
Chief Executive Officer, Director
Chief Executive Officer, Director
1.35M
-14830.00%
Mr. Jon Mark Foster
Mr. Jon Mark Foster
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
150.39K
-16778.00%
Dr. Michael S. Cuffe, M.D.
Dr. Michael S. Cuffe, M.D.
Executive Vice President, Chief Clinical Officer
Executive Vice President, Chief Clinical Officer
31.43K
--
Mr. Robert Jay (Bob) Dennis
Mr. Robert Jay (Bob) Dennis
Independent Director
Independent Director
26.60K
+1026.00%
Dr. Wayne Joseph Riley, M.D.
Dr. Wayne Joseph Riley, M.D.
Independent Director
Independent Director
14.52K
+645.00%
Mr. Michael W. Michelson, J.D.
Mr. Michael W. Michelson, J.D.
Independent Director
Independent Director
11.65K
+1173.00%
Dr. Sammie S. Mosier
Dr. Sammie S. Mosier
Senior Vice President, Chief Nurse Executive
Senior Vice President, Chief Nurse Executive
11.11K
+715.00%
Ms. Andrea B. Smith
Ms. Andrea B. Smith
Independent Director
Independent Director
4.24K
+645.00%
Mr. Hugh F. Johnston
Mr. Hugh F. Johnston
Independent Director
Independent Director
3.67K
+1026.00%
Mr. Thomas F. Frist, III
Mr. Thomas F. Frist, III
Chairman of the Board
Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Samuel N. (Sam) Hazen
Mr. Samuel N. (Sam) Hazen
Chief Executive Officer, Director
Chief Executive Officer, Director
1.35M
-14830.00%
Mr. Jon Mark Foster
Mr. Jon Mark Foster
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
150.39K
-16778.00%
Dr. Michael S. Cuffe, M.D.
Dr. Michael S. Cuffe, M.D.
Executive Vice President, Chief Clinical Officer
Executive Vice President, Chief Clinical Officer
31.43K
--
Mr. Robert Jay (Bob) Dennis
Mr. Robert Jay (Bob) Dennis
Independent Director
Independent Director
26.60K
+1026.00%
Dr. Wayne Joseph Riley, M.D.
Dr. Wayne Joseph Riley, M.D.
Independent Director
Independent Director
14.52K
+645.00%
Mr. Michael W. Michelson, J.D.
Mr. Michael W. Michelson, J.D.
Independent Director
Independent Director
11.65K
+1173.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
American group
6.69B
34.90%
Atlantic Group
6.14B
32.05%
National group
5.53B
28.83%
Corporate and other
806.00M
4.21%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: seg, 17 de nov
Atualizado em: seg, 17 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Hercules Holding II
30.20%
The Vanguard Group, Inc.
6.49%
Sanders Capital, LLC
4.68%
BlackRock Institutional Trust Company, N.A.
3.40%
State Street Investment Management (US)
3.28%
Outro
51.95%
Investidores
Investidores
Proporção
Hercules Holding II
30.20%
The Vanguard Group, Inc.
6.49%
Sanders Capital, LLC
4.68%
BlackRock Institutional Trust Company, N.A.
3.40%
State Street Investment Management (US)
3.28%
Outro
51.95%
Tipos de investidores
Investidores
Proporção
Investment Advisor
34.35%
Corporation
30.20%
Investment Advisor/Hedge Fund
19.36%
Pension Fund
2.11%
Hedge Fund
1.75%
Bank and Trust
1.39%
Sovereign Wealth Fund
1.39%
Research Firm
1.32%
Individual Investor
1.16%
Outro
6.98%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
2307
141.21M
61.88%
-14.09M
2025Q3
2301
148.00M
64.85%
-12.53M
2025Q2
2310
229.16M
97.93%
-11.11M
2025Q1
2325
230.33M
95.69%
-9.90M
2024Q4
2258
234.95M
94.56%
-4.46M
2024Q3
2192
234.05M
91.76%
-11.07M
2024Q2
2126
239.45M
92.36%
-7.50M
2024Q1
2117
240.61M
92.66%
-8.64M
2023Q4
2082
243.30M
92.89%
-5.45M
2023Q3
2034
242.79M
88.27%
-10.13M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Hercules Holding II
68.91M
30.2%
--
--
Feb 24, 2025
The Vanguard Group, Inc.
14.80M
6.49%
-581.67K
-3.78%
Sep 30, 2025
Sanders Capital, LLC
10.68M
4.68%
-426.92K
-3.85%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
7.76M
3.4%
-305.28K
-3.79%
Sep 30, 2025
State Street Investment Management (US)
7.49M
3.28%
-466.06K
-5.86%
Sep 30, 2025
Capital World Investors
4.96M
2.17%
+179.44K
+3.75%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
3.92M
1.72%
-290.38K
-6.90%
Sep 30, 2025
Wellington Management Company, LLP
3.88M
1.7%
-230.12K
-5.60%
Sep 30, 2025
Geode Capital Management, L.L.C.
3.65M
1.6%
-147.76K
-3.89%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
3.01M
1.32%
+208.56K
+7.45%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares U.S. Healthcare Providers ETF
5%
God Bless America ETF
4.62%
Argent Mid Cap ETF
4.33%
Invesco Dynamic Buyback Achievers ETF
3.87%
LeaderShares AlphaFactor Tactical Focused ETF
3.11%
First Eagle Global Equity ETF
2.83%
JPMorgan Equity Focus Fund
2.74%
State Street SPDR S&P Health Care Services ETF
2.38%
Strategas Macro Momentum ETF
2.34%
Brandes US Value ETF
2.26%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção5%
God Bless America ETF
Proporção4.62%
Argent Mid Cap ETF
Proporção4.33%
Invesco Dynamic Buyback Achievers ETF
Proporção3.87%
LeaderShares AlphaFactor Tactical Focused ETF
Proporção3.11%
First Eagle Global Equity ETF
Proporção2.83%
JPMorgan Equity Focus Fund
Proporção2.74%
State Street SPDR S&P Health Care Services ETF
Proporção2.38%
Strategas Macro Momentum ETF
Proporção2.34%
Brandes US Value ETF
Proporção2.26%

Dividendo

Um total de 2.63B USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Oct 24, 2025
HCA.NB Final Cash Dividend of gross USD 0.72 paid on Dec 29, 2025 going ex on Dec 15, 2025
Dec 15, 2025
Dec 29, 2025
Dec 15, 2025
Jul 25, 2025
HCA.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 30, 2025 going ex on Sep 16, 2025
Sep 16, 2025
Sep 30, 2025
Sep 16, 2025
Apr 25, 2025
HCA.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 30, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jun 30, 2025
Jun 16, 2025
Jan 24, 2025
HCA.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 31, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 31, 2025
Mar 17, 2025
Oct 25, 2024
HCA.NB Final Cash Dividend of gross USD 0.66 paid on Dec 27, 2024 going ex on Dec 13, 2024
Dec 13, 2024
Dec 27, 2024
Dec 13, 2024
Jul 23, 2024
HCA.NB Interim Cash Dividend of gross USD 0.66 paid on Sep 30, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Sep 30, 2024
Sep 16, 2024
Apr 26, 2024
HCA.NB Interim Cash Dividend of gross USD 0.66 paid on Jun 28, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jun 28, 2024
Jun 14, 2024
Jan 30, 2024
HCA.NB Interim Cash Dividend of gross USD 0.66 paid on Mar 29, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Mar 29, 2024
Mar 14, 2024
Oct 24, 2023
HCA.NB Final Cash Dividend of gross USD 0.6 paid on Dec 28, 2023 going ex on Dec 13, 2023
Dec 14, 2023
Dec 28, 2023
Dec 13, 2023
Jul 27, 2023
HCA.NB Interim Cash Dividend of gross USD 0.6 paid on Sep 29, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Sep 29, 2023
Sep 14, 2023
Ver Mais

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados

Perguntas frequentes

Quem são os cinco principais acionistas de HCA Healthcare Inc?

Os cinco principais acionistas de HCA Healthcare Inc são:
Hercules Holding II detém 68.91M Ações, representando 30.20% do total de Ações.
The Vanguard Group, Inc. detém 14.80M Ações, representando 6.49% do total de Ações.
Sanders Capital, LLC detém 10.68M Ações, representando 4.68% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 7.76M Ações, representando 3.40% do total de Ações.
State Street Investment Management (US) detém 7.49M Ações, representando 3.28% do total de Ações.

Quais são os três principais tipos de acionistas de HCA Healthcare Inc?

Os três principais tipos de acionistas da HCA Healthcare Inc são:
Hercules Holding II
The Vanguard Group, Inc.
Sanders Capital, LLC

Quantas instituições possuem ações da HCA Healthcare Inc (HCA)?

Em 2025Q4, 2307 instituições possuíam ações da HCA Healthcare Inc, com valor de mercado aproximado de 141.21M, representando 61.88% do total de ações. Em comparação com 2025Q3, a participação institucional aumentou em -2.97%.

Qual é a maior fonte de receita da HCA Healthcare Inc?

Em FY2025Q3, o segmento de negócios -- gerou a maior receita para HCA Healthcare Inc, totalizando -- e representando --% da receita total.
KeyAI